Literature DB >> 666331

Hereditary congenital hypopigmented and hyperpigmented macules.

W Westerhof, F A Beemer, R H Cormane, J W Delleman, W R Faber, J G de Jong, W W van der Schaar.   

Abstract

Congenital hypomelanotic and hypermelanotic macules traced in three generations of a family suggested autosomal dominant inheritance. Some affected membbers also showed retarded growth and mental deficiency. Light microscopic findings of "splitdopa" preparations of lesional and normal skin were comparable, except that background staining of keratinocytes in dark macules was higher than in control skin. In light macules it was lower. Ultrastructurally, hypomelanotic skin showed small melanosomes (0.3 mu) that occurred in keratinocytes in melanosome complexes. Hypermelanotic skin revealed large melanosomes (0.6 mu) that were singly distributed in keratinocytes. Melanosome size in normal skin averaged 0.4 mu; distribution pattern was mixed. Melanin granules inside keratinocytes were fully melanized. Hyperpigmented, normal and hypopigmented skin of one person had histological features of black oriental and white skin. This clinical picture could well represent a new neurocutaneous syndrome different from tuberous sclerosis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 666331

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  3 in total

Review 1.  Neurology and the skin.

Authors:  O Hurko; T T Provost
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-04       Impact factor: 10.154

2.  Familial progressive hyper- and hypopigmentation: a report on a Chinese family and evidence for genetic heterogeneity.

Authors:  Fang Xiao-Kai; He Yue-Xi; Li Yan-Jia; Chen Li-Rong; Wang He-Peng; Sun Qing
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

3.  Café au lait spots in ataxia-telangiectasia (A.T.). Histochemical and ultrastructural study in one case.

Authors:  J P Ortonne; A L Claudy; F Freycon
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.